SODIUM CHLORIDE, MYDRIASERT, insert ophtalmique, 0.34 % tropicamide/ 2.5 % phenylephrine hydrochloride
UP-CLI-2023-01
Phase 2 small_molecule active
Quick answer
SODIUM CHLORIDE, MYDRIASERT, insert ophtalmique, 0.34 % tropicamide/ 2.5 % phenylephrine hydrochloride for to obtain pre-operative mydriasis or for diagnostic purposes is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- to obtain pre-operative mydriasis or for diagnostic purposes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active